An analysis of nearly 300 recently identified human SARS-CoV-2 antibodies uncovered a gene frequently used in antibodies that most effectively target the virus. The results contribute to growing structural insight that will be needed for successful vaccine development against SARS-CoV-2.
As the global COVID-19 pandemic continues, multiple vaccine candidates have entered clinical trials. Yet, the molecular features that contribute to the most effective antibody response remain unclear.
The spike protein of SARS-CoV-2 uses its receptor binding domain (RBD) to infect the host receptor, ACE2, on human cells. Antibodies that could target RBD and block binding to ACE2 are highly sought, and a number have been discovered.
The researchers compiled a list of 294 such RBD-targeting antibodies. By analyzing them, they found that a gene in the IGHV gene family, known as IGHV3-53, is the most frequently used IGHV gene for targeting the RBD of the virus spike protein. IGHV3-53 antibodies, the authors say, not only have lower mutation rates but are also more potent.
By studying the crystal structures of two IGHV3-53 antibodies bound to the RBD with or without Fab CR3022, at 2.33 to 3.20 Å resolution revealed that the germline-encoded residues dominate recognition of the ACE2 binding site.. This binding mode limits the IGHV3-53 antibodies to short CDR H3 loops, but accommodates light-chain diversity. These IGHV3-53 antibodies show minimal affinity maturation and high potency, which is promising for vaccine design.
This detailed insight into IGHV-53 neutralizing antibodies should facilitate design of vaccine antigens that elicit this type of neutralizing antibody response, the authors say. "As IGHV3-53 is found at a reasonable frequency in healthy individuals, this particular antibody response could be commonly elicited during vaccination," they write.
https://science.sciencemag.org/content/early/2020/07/10/science.abd2321
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Fstructural-basis-of-a&filter=22
A Gene in SARS-CoV-2 Antibody to Target the Virus Protein Identified!
- 988 views
- Added
Edited
Latest News
How our cells kill themselves
By newseditor
Posted 27 May
AI predicts the function of…
By newseditor
Posted 27 May
Hippocampo-cortical circuit…
By newseditor
Posted 26 May
A tumor protein p63 isoform…
By newseditor
Posted 24 May
Brain signatures for chroni…
By newseditor
Posted 24 May
Other Top Stories
New computer model to track cell fate!
Read more
Spinal cord vascularization during motor neuron development
Read more
Spine development without segmentation clocks
Read more
Cilia helps in the left/right turn during embryogenesis
Read more
Human accelerated regions in primate neurodevelopment
Read more
Protocols
Designed active-site librar…
By newseditor
Posted 27 May
A microfluidics-enabled aut…
By newseditor
Posted 22 May
TomoTwin: generalized 3D lo…
By newseditor
Posted 17 May
Optimization and validation…
By newseditor
Posted 16 May
EmbryoNet: using deep learn…
By newseditor
Posted 12 May
Publications
Structural basis of NINJ1-m…
By newseditor
Posted 27 May
A general model to predict…
By newseditor
Posted 27 May
Emerging frontiers in regen…
By newseditor
Posted 27 May
Promoting regeneration whil…
By newseditor
Posted 27 May
Massively parallel base edi…
By newseditor
Posted 27 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 10 Mar
ASCO-2020-GYNECOLOGIC CANCER
By newseditor
Posted 10 Mar